Nanobiotix
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Nanobiotix and buy or sell other stocks, ETFs, and their options commission-free!About NBTX
Nanobiotix SA is a late-stage biotechnology company, which engages in the development of therapeutic approaches to the treatment of cancer. Its technologies include NanoXray that improves the efficacy of radiation therapy against tumor cells.
CEOLaurent Lévy
CEOLaurent Lévy
Employees108
Employees108
HeadquartersParis, Ile-de-France
HeadquartersParis, Ile-de-France
Founded2003
Founded2003
Employees108
Employees108
NBTX Key Statistics
Market cap1.33B
Market cap1.33B
Price-Earnings ratio-35.42
Price-Earnings ratio-35.42
Dividend yield—
Dividend yield—
Average volume158.27K
Average volume158.27K
High today$28.39
High today$28.39
Low today$26.57
Low today$26.57
Open price$26.57
Open price$26.57
Volume60.86K
Volume60.86K
52 Week high$30.35
52 Week high$30.35
52 Week low$2.76
52 Week low$2.76
NBTX News
TipRanks 9h
Nanobiotix Updates Voting Rights and Share Capital DetailsElevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...
Barchart 6d
This Stock Is Up 440% in a Year. Is It an Undiscovered Star or a Flash in the Pan?Nanobiotix (NBTX) is a clinical-stage nanomedicine company showing exceptional price momentum and technical strength. Shares are trading at new all-time highs....
Analyst ratings
100%
of 7 ratingsBuy
100%
Hold
0%
Sell
0%